name: alpha tocopherol / ascorbic acid / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide


name: alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1


name: Standardized Animal Hair Allergenic Extract


name: Standardized Animal Skin Allergenic Extract


name: Standardized Insect Venom Allergenic Extract


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Falmina 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Loestrin Fe 1.5/30 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Elinest 28 Day]


name: alpha tocopherol / ascorbic acid / biotin / dexpanthenol / ergocalciferol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1


name: {7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Lo-Marzia 28-Day]


name: cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil


name: Health Services Geographic Accessibility


name: Multiplex Ligation-Dependent Probe Amplification


name: Immunoreceptor Tyrosine-Based Inhibition Motif


name: Renal Epithelial Sodium Channel Inhibitors


name: Optically Stimulated Luminescence Dosimetry


name: Supplemental Nutrition Assistance Program


name: Titanium Plate Mandibular Reconstruction


name: Native Polyacrylamide Gel Electrophoresis


name: urine aromatic solvent metabolites - phenol measurement (lab test)


name: Extended radical mastectomy of bilateral breasts


name: Glossectomy, less than one-half of tongue


name: Ureteropyelostomy, anastomosis of ureter and renal pelvis


name: HEDIS 2009-2013 Codes to identify postpartum visits (PPC-E)


name: Risk for venous thromboembolism:Imp:Pt:^Patient:Ord


name: {1 (Bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (POLYETHYLENE GLYCOL 3350 105 MG/ML / Potassium Chloride 0.00497 MEQ/ML / Sodium Bicarbonate 0.017 MEQ/ML / Sodium Chloride 0.0479 MEQ/ML Oral Solution [Halflytely]) } Pack [Halflytely and Bisacodyl Bowel Prep Reformulated Aug 2010]


name: (Ifosfamide 50 MG/ML Injectable Solution) / (Mesna 100 MG/ML Injectable Solution) Pack Includes 10/10 & 5/3 Kit


name: {1 (4000 MG) (hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream [Analpram HC]) / 1 (pramoxine hydrochloride 10 MG/ML Medicated Pad [Prax]) } Pack [Analpram E Kit with 1 Prax Medicated Pad]


name: Revision of total shoulder arthroplasty, including allograft when performed; humeral and glenoid component


name: Revision of total shoulder arthroplasty, including allograft when performed; humeral or glenoid component


name: Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open femoral artery approach


name: Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open axillary artery approach


name: MR angiography of lower leg without and with contrast


name: Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open iliac artery approach


name: Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transaortic approach (eg, median sternotomy, mediastinotomy)


name: Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with percutaneous peripheral arterial and venous cannulation (eg, femoral vessels) (List separately in addition to code for primary procedure)


name: Department of Veterans Affairs Medical Benefits Plan


name: Department of Defense Medical Benefits Plan - (other)


name: Department of Defense Medical Benefits Plan


name: Other Federal Agency provided medical care


name: Department of Veterans Affairs provided non-veteran care


name: No charge for medical care due to enrollment in research/clinical trial


name: No charge for medical care due to special research funding including live organ donor status


name: Other (Non-government) source of payment


name: Body site identification panel:-:Pt:^Patient:-


name: {84 (cabozantinib 20 MG Oral Capsule [Cometriq]) } Pack [Cometriq 60 MG Daily Dose Carton]


name: Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed; cessation of thrombolysis including removal of catheter and vessel closure by any method


name: Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed


name: urine drug screen by multiple class procedure, chromatographic method


name: Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with open peripheral arterial and venous cannulation (eg, femoral, iliac, axillary vessels) (List separately in addition to code for primary procedure)


name: Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (eg, aorta, right atrium, pulmonary artery) (List separately in addition to code for primary procedure)


name: {1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG Oral Capsule) } Pack


name: Consultation note - recommended C-CDA R1.1 sections:-:Pt:{Setting}:-


name: Consultation note - recommended C-CDA R1.1 sections


name: Continuity of Care Document - recommended C-CDA R1.1 sections


name: Continuity of Care Document - recommended C-CDA R1.1 sections:-:Pt:{Setting}:-


name: Diagnostic imaging report - recommended C-CDA R1.1 sections


name: Diagnostic imaging report - recommended C-CDA R1.1 sections:-:Pt:{Setting}:-


name: Discharge summary - recommended C-CDA R1.1 sections


name: Discharge summary - recommended C-CDA R1.1 sections:-:Pt:{Setting}:-


name: Edge of wound description:Type:Pt:Wound.edge:Nom


name: VKORC1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Influenza virus A hemagglutinin segment sequence identifier:ID:Pt:Isolate:Nom:Sequencing


name: Thyroid imaging (including vascular flow, when performed); with single or multiple uptake(s) quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)


name: HEDIS 2009-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Valproate (MPM-E)


name: HEDIS 2009-2013 Codes to identify cervical cancer screening tests (CCS-A)


name: HEDIS 2009-2013 Codes to identify lead (LSC-A)


name: HEDIS 2010-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Carbamazepine (MPM-E)


name: HEDIS 2010-2013 Codes to identify Chlamydia screening (CHL-C)


name: HEDIS 2010-2013 Tests used in early prenatal care - Rubella (PPC-C)


name: HEDIS 2011-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Phenytoin (MPM-E)


name: HEDIS 2011-2013 Codes to identify evidence of nephropathy (CDC-K)


name: HEDIS 2011-2013 Codes to identify LDLc screening (CDC-H)


name: HEDIS 2011-2013 Codes to identify LDLc screening (CMC-D)


name: HEDIS 2011-2013 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A)


name: HEDIS 2011-2013 Tests used in early prenatal care - Herpes simplex (PPC-C)


name: HEDIS 2011-2013 Tests used in early prenatal care - Toxoplasma (PPC-C)


name: HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)


name: HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests - Phenobarbital (MPM-E)


name: HEDIS 2012, 2013 Codes to identify colorectal cancer screening (COL-A)


name: HEDIS 2012, 2013 Codes to identify HbA1c tests (CDC-D)


name: HEDIS 2012, 2013 Codes to identify nephropathy screening tests (CDC-J)


name: HEDIS 2012, 2013 Codes to identify physiologic monitoring tests (MPM-A)


name: HEDIS 2012, 2013 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A)


name: HEDIS 2012, 2013 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A)


name: HEDIS 2012, 2013 Tests used in early prenatal care (PPC-C)


name: HEDIS 2012, 2013 Tests used in early prenatal care - Cytomegalovirus (PPC-C)


name: HEDIS 2013 Codes to identify group A Streptococcus tests (CWP-D)


name: HEDIS 2013 Codes to identify group A Streptococcus tests (CWP-D):-:Pt:^Patient:-


name: HEDIS 2013 Codes to identify sexually active women (CHL-B):-:Pt:^Patient:-


name: HEDIS 2013 Codes to identify sexually active women (CHL-B)


name: History and physical note - recommended C-CDA R1.1 & R2.0 & R2.1 sections


name: History and physical note - recommended C-CDA R1.1 & R2.0 & R2.1 sections:-:Pt:{Setting}:-


name: Patient reported outcome quality of life tool:-:Pt:^Patient:-


name: Patient reported outcome quality of life tool


name: Permission to release immunization data from school record


name: Permission to release immunization data from school record:Find:Pt:^Patient:Ord


name: Procedure note - recommended C-CDA R1.1 sections


name: Progress note - recommended C-CDA R1.1 sections:-:Pt:{Setting}:-


name: Progress note - recommended C-CDA R1.1 sections


name: Pain severity - 0-10 verbal numeric rating:Score:Pt:^Patient:Qn:Reported


name: Sagittal plane body position:Angle:Pt:^Patient:Ord


name: Surgical operation note - recommended C-CDA R1.1 & R2.0 & R2.1 sections


name: Surgical operation note - recommended C-CDA R1.1 & R2.0 & R2.1 sections:-:Pt:{Setting}:-


name: Electrolytes with Various Carbohydrates Solution for injection


name: Introduction of Glucarpidase into Peripheral Vein, Percutaneous Approach


name: Introduction of Glucarpidase into Central Vein, Percutaneous Approach


name: TITANIUM DIOXIDE 6.4 mL in 80 mL / OCTINOXATE 2 mL in 80 mL TOPICAL LIQUID [Jafra Always Color Stay-on Makeup SPF 10]


name: CATHETER,URETHRAL 9FR,COUDE TIP DILATION BALLOON #G17842


name: CATHETER,URETHRAL 9FR,FILIFORM TIP DILATION BALLOON #G17843


name: TRACH STOMA PROTECTOR,FOAM 2IN X 2.5IN LUMINAUD #63041


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Mono-Linyah 28 Day]


name: chlorpheniramine / ibuprofen / phenylephrine


name: {10 (12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet [Kapvay]) / 10 (12 HR clonidine hydrochloride 0.2 MG Extended Release Oral Tablet [Kapvay]) } Pack [Kapvay Dose Pack]


name: Avobenzone 20 mg in 1 g / Homosalate 30 mg in 1 g / Oxybenzone 50 mg in 1 g / Octinoxate 75 mg in 1 g TOPICAL CREAM [Skincare LdeL Retinol Day Broad Spectrum SPF 20]


name: GLYCERIN 20 g in 100 g TOPICAL GEL [Dynarex Hydrogel]


name: Non-Standardized Animal Dander Allergenic Extract


name: Non-Standardized Animal Hair Allergenic Extract


name: Non-Standardized Animal Skin Allergenic Extract


name: Non-Standardized Bacterial Allergenic Extract


name: Non-Standardized Feather Allergenic Extract


name: Non-Standardized Food Allergenic Extract


name: Non-Standardized Fungal Allergenic Extract


name: Non-Standardized House Dust Allergenic Extract


name: Non-Standardized Insect Allergenic Extract


name: Non-Standardized Insect Venom Allergenic Extract


name: Non-Standardized Plant Allergenic Extract


name: Non-Standardized Plant Fiber Allergenic Extract


name: Non-Standardized Pollen Allergenic Extract


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [TRI-LINYAH]


name: PETROLATUM 450 mg in 1 g TOPICAL STICK [ChapStick Classic Cherry]


name: OCTINOXATE 3.5 g in 50 mL TOPICAL CREAM [Optimal Tinted Complexion]


name: CATHETER,FOLEY DOVER 12FR 30ML KENDALL #403712


name: CATHETER,FOLEY DOVER 14FR 30ML KENDALL #403714


name: CATHETER,FOLEY DOVER 16FR 30ML KENDALL #403716


name: CATHETER,FOLEY DOVER 18FR 30ML KENDALL #403718


name: CATHETER,INTERMITTENT COUDE 12FR H #95124


name: CATHETER,INTERMITTENT COUDE 14FR H #95144


name: CATHETER,INTERMITTENT COUDE 16FR H #95164


name: FEEDING BAG W/PUMP SET COVIDIEN #72024600


name: SALIVA EJECTOR,WHITE OPAQUE HENRY SCHEIN #1005205


name: alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / docusate / ferrous fumarate / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide


name: Aluminum Zirconium Tetrachlorohydrex Gly 1.2 g in 75 g TOPICAL STICK [Ralph Lauren Romance Antiperspirant Deodorant]


name: OCTINOXATE 3 g in 100 mL / TITANIUM DIOXIDE 3 g in 100 mL / ZINC OXIDE 9 g in 100 mL TOPICAL EMULSION [Neova DNA Damage Control - Silc Sheer Broad Spectrum SPF 40]


name: Octinoxate 6.5 g in 100 mL / Octisalate 2.5 g in 100 mL / Zinc Oxide 8.5 g in 100 mL TOPICAL EMULSION [Neova DNA Damage Control - Everyday Broad Spectrum SPF 44]


name: OCTINOXATE 7.5 g in 100 mL / ZINC OXIDE 9 g in 100 mL TOPICAL EMULSION [Neova DNA Damage Control - Active Broad Spectrum SPF 43]


name: TITANIUM DIOXIDE 4.2 g in 100 mL TOPICAL CREAM [FACE GUARD 15]


name: dexpanthenol / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12


name: OCTINOXATE 3.5 g in 50 mL / TITANIUM DIOXIDE .5 g in 50 mL TOPICAL CREAM [Face Guard 30 SPF]


name: OCTINOXATE 1.8 g in 30 mL TOPICAL CREAM [Long Last Makeup 00]


name: copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate


name: ascorbic acid / biotin / copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacin / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc sulfate


name: copper sulfate / ferrous fumarate / folic acid / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate


name: copper sulfate / ferrous fumarate / folic acid / magnesium sulfate / manganese sulfate / niacinamide / pantothenate / polysaccharide iron complex / pyridoxine / riboflavin / sodium ascorbate / thiamine / vitamin B12 / zinc sulfate


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 46 mg in 1 mL / AVOBENZONE 2 mg in 1 mL TOPICAL CREAM [3LAB Hydra Day SPF 20 Broad Spectrum Water-Based Sunscreen]


name: Octinoxate 75 mg in 1 mL / Titanium Dioxide 20 mg in 1 mL / Zinc Oxide 171 mg in 1 mL TOPICAL CREAM [Algenist]


name: ALUMINUM CHLORIDE 12 mg in 1 mL TOPICAL LIQUID [Clinical Strength MiracleDry Antiperspirant Deodorant PM]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 18 mg in 1 mL TOPICAL LIQUID [Clinical Strength MiracleDry Antiperspirant Deodorant AM]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 ug in 1 g TOPICAL STICK [Softlips Marshmallow Ghost]


name: OCTINOXATE 63.4 mg in 1 g / TITANIUM DIOXIDE 30 mg in 1 g TOPICAL CREAM [Extralasting Cream-to-Powder Foundation]


name: TITANIUM DIOXIDE 53.9 mg in 1 mL TOPICAL LOTION [Extralasting Liquid Foundation]


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Kurvelo]


name: allantoin / camphor / hexylresorcinol / menthol


name: benzalkonium / hexylresorcinol / zinc chloride


name: {1 (acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: astaxantin, calcium, citrus bioflavoid, lycopene, vitamin D3 drug combination


name: aluminum hydroxide / calcium carbonate / magnesium hydroxide


name: gelatin, glycerin, zinc oxide drug combination


name: casein, magnesium carbonate, pectin, potassium bicarbonate drug combination


name: camphor, cedar leaf oil, eucalyptus oil, menthol, myristica oil, terebinth oil, thymol drug combination


name: dihydroergotoxine mesylate, esculoside, rutoside drug combination


name: Selective catheter placement, common carotid or innominate artery, unilateral, any approach, with angiography of the ipsilateral extracranial carotid circulation and all associated radiological supervision and interpretation, includes angiography of the cervicocerebral arch, when performed


name: ascorbic acid, B2, B6, bendazol, caffeine, citric acid, distilled H2O, ethanol, gelatin, glutamic acid, KCl, MgCl2, NaCl, sorbitol, sucrose, vitamins B1 drug combination


name: Selective catheter placement, common carotid or innominate artery, unilateral, any approach, with angiography of the ipsilateral intracranial carotid circulation and all associated radiological supervision and interpretation, includes angiography of the extracranial carotid and cervicocerebral arch, when performed


name: Percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch


name: Percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (List separately in addition to code for primary procedure)


name: leptadenia reticulata - pharmacologic substance


name: {25 (calcium carbonate 500 MG Chewable Tablet [Tums]) / 140 (calcium carbonate 750 MG Chewable Tablet [Tums]) } Pack [Tums Freshers and Extra Strength]


name: {160 (calcium carbonate 1000 MG Chewable Tablet [Tums]) / 25 (calcium carbonate 500 MG Chewable Tablet [Tums]) } Pack [Tums Freshers and Ultra Strength]


name: Cepacol Sore Throat (benzocaine / menthol)


name: INJECTION, MEDROXYPROGESTERONE ACETATE, 1 MG


name: {28 (cabozantinib 20 MG Oral Capsule [Cometriq]) / 28 (cabozantinib 80 MG Oral Capsule [Cometriq]) } Pack [Cometriq 100 MG Daily Dose Carton]


name: {84 (cabozantinib 20 MG Oral Capsule [Cometriq]) / 28 (cabozantinib 80 MG Oral Capsule [Cometriq]) } Pack [Cometriq 140 MG Daily Dose Carton]


name: Rwanda Health Enterprise Architecture survey


name: camphor / capsaicin / menthol / methyl salicylate / peppermint oil / zinc oxide


name: AVOBENZONE 1286 mg in 51.45 g / OCTINOXATE 3807 mg in 51.45 g / OCTOCRYLENE 1029 mg in 51.45 g TOPICAL CREAM [SHISEIDO BENEFIANCE NUTRIPERFECT DAY]


name: OCTINOXATE 5.5 g in 100 g / OCTOCRYLENE 2.0 g in 100 g / AVOBENZONE 2.0 g in 100 g / OXYBENZONE 3.5 g in 100 g TOPICAL LIPSTICK [LypSyl Honeyberry]


name: BAG,LEG LATEX REUSABLE 32OZ RELIAMED #ZRLB4157


name: BANDAGE,ELASTIC,CONFORMING (MOLLELAST) 2.4IN X 4.4YD


name: DRESSING,RESTORE SILVER 4IN X 5IN H#509341


name: DRESSING,RESTORE SILVER 6IN X 8IN H#509342


name: DRESSING,RESTORE,CONTACT LAYER 2IN X 2IN H#506487


name: DRESSING,RESTORE,CONTACT LAYER 4IN X 5IN H#506488


name: DRESSING,RESTORE,CONTACT LAYER 6IN X 8IN H#506489


name: LARYNGEAL PROSTHESIS CLEANING BRUSH,BLOM-SINGER LARGE


name: LARYNGEAL PROSTHESIS CLEANING BRUSH,BLOM-SINGER MEDIUM


name: LARYNGEAL PROSTHESIS CLEANING BRUSH,BLOM-SINGER SMALL


name: LARYNGEAL PROSTHESIS FLUSHING DEVICE,BLOM-SINGER IN4050


name: POUCH,DRAINABLE,CENTER POINT LOCK H#3814


name: TUBING,LATEX EXTENSION 9/32IN (ID) BARD #6A4194


name: OCTOCRYLENE 5 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OXYBENZONE 3 g in 100 mL / TITANIUM DIOXIDE 3 g in 100 mL TOPICAL CREAM [Sunscreen Creme SPF 37 Exel]


name: AVOBENZONE 0.93 g in 31 g / HOMOSALATE 2.48 g in 31 g / OCTISALATE 1.24 g in 31 g / OCTOCRYLENE 0.729 g in 31 g / OXYBENZONE 1.55 g in 31 g TOPICAL EMULSION [Anti-Aging Complex SPF 30 Merle Norman]


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 60 mg in 1 mL TOPICAL CREAM [Boscia Daily Hydration SPF 15 Broad Spectrum For Normal To Oily Skin]


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 75 mg in 1 mL TOPICAL CREAM [Boscia Self-Defense Vital Antioxidant Moisture Broad Spectrum SPF 30]


name: OCTINOXATE 7.25 g in 100 g / TITANIUM DIOXIDE 5.742 g in 100 g / ZINC OXIDE 4.75 g in 100 g TOPICAL CREAM [Boscia Daily Defense Sunscreen Broad Spectrum SPF 50 PA]


name: TITANIUM DIOXIDE 10.02 g in 100 g / ZINC OXIDE 0.97 g in 100 g TOPICAL CREAM [Boscia BB Broad Spectrum SPF 27 PA Self Adjusting Shade]


name: TITANIUM DIOXIDE 11.25 g in 100 g / ZINC OXIDE 0.98 g in 100 g TOPICAL CREAM [Boscia B.B. LIGHT Broad Spectrum SPF 27 PA Self-Adjusting Shade]


name: TITANIUM DIOXIDE 7.55 g in 100 g / ZINC OXIDE 0.98 g in 100 g TOPICAL CREAM [Boscia BB BRONZE Broad Spectrum SPF 27 PA Self-Adjusting Shade]


name: chromium, chelated / manganese gluconate / zinc citrate


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 40 mg in 1 mL TOPICAL LOTION [Magix Face Perfector]


name: octinoxate 75 mg in 1 g / oxybenzone 40 mg in 1 g / avobenzone 20 mg in 1 g TOPICAL CREAM [Anew Clinical Absolute Even Spot Correcting Hand]


name: camphor / dimethicone / menthol / phenol


name: {7 (perampanel 2 MG Oral Tablet) / 7 (perampanel 4 MG Oral Tablet) } Pack


name: {7 (perampanel 2 MG Oral Tablet [FYCOMPA]) / 7 (perampanel 4 MG Oral Tablet [FYCOMPA]) } Pack [Fycompa 2/4 Sample Pack]


name: TITANIUM DIOXIDE 33.9 mg in 1 mL TOPICAL LOTION [magix Cashmere Finish Liquid Foundation]


name: OCTINOXATE 1.18 g in 16 g / ZINC OXIDE 1.04 g in 16 g TOPICAL LOTION [Anti-Aging Complex Eye Treatment Merle Norman]


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 65 mg in 1 mL TOPICAL CREAM [Boscia Restorative Day Moisture Broad Spectrum SPF 15 For Dry Skin]


name: OCTINOXATE 9.36 g in 234 g / AVOBENZONE 7.02 g in 234 g TOPICAL LOTION [SunZone Baby Sunscreen SPF-60 Broad Spectrum]


name: Revision of total elbow arthroplasty, including allograft when performed; humeral and ulnar component


name: Instrument-based ocular screening (eg, photoscreening, automated-refraction), bilateral; with remote analysis and report


name: Anesthesia for removal of external pelvic nerve


name: Anesthesia for removal of internal pelvic nerve


name: Removal of growth and lymph nodes of chest wall and ribs


name: Placement of graft to aorta on heart-lung machine


name: Insertion of needle or catheter into the brachial (arm) artery


name: Injection of chemical agent into spider veins of face


name: Transection of esophagus with repair for esophageal varices


name: Destruction of polyps or growths of large bowel using an endoscope


name: Removal of polyps or growths in large bowel using an endoscope


name: Transplantation of donor liver to alternate anatomic position


name: Incision of skull to reduce brain pressure


name: Excision of skull base to sever nerve tract to brain stem


name: Excision of skull to sever a nerve tract to midbrain


name: Incision of skull and brain frontal lobe


name: Incision or tying of carotid artery at skull base


name: Incision or tying of carotid artery at skull base with graft


name: Implantation of brain neurostimulator electrodes


name: Reduction and reshaping of an enlarged skull


name: Connection of nerves to restore function to the face


name: Ultrasonic guidance for administration of radiation therapy


name: Nuclear medicine study of brain and spinal cord fluid flow


name: Thyrotropin releasing hormone (TRH) (hypothalamus hormone) stimulation panel


name: Chemical analysis using chromatography technique


name: Assessment and recording of balance system during irrigation of both ears


name: Catheter based enlargement of opening between two upper heart chambers


name: Inhalation of allergic substances with reaction analysis


name: Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes


name: Surgical creation of drainage tract to relieve increased eye pressure


name: Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)


name: Localization and tracking of target or patient motion during radiation therapy delivery


name: Examination and biopsy of anus using an endoscope


name: HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL TOPICAL CREAM [Cellular Laboratories De-Aging Sunscreen Broad Spectrum SPF 50 Plus]


name: {7 (24 HR rotigotine 0.0833 MG/HR Transdermal System) / 7 (24 HR rotigotine 0.167 MG/HR Transdermal System) } Pack


name: {7 (24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]) / 7 (24 HR rotigotine 0.167 MG/HR Transdermal System [Neupro]) } Pack [Neupro Kit]


name: chlophedianol / phenylephrine / thonzylamine


name: BRIEF,BREATHABLE OVERNIGHT LARGE ATTENDS


name: BRIEF,BREATHABLE OVERNIGHT MEDIUM ATTENDS


name: BRIEF,BREATHABLE OVERNIGHT X-LARGE ATTENDS


name: hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain


name: OCTINOXATE 7.5 g in 100 g / TITANIUM DIOXIDE 5.12 g in 100 g TOPICAL LIQUID [Sheer Defense Tinted Moisturizer SPF 15 L10 Merle Norman]


name: betaine / bromelains / pancreatin / papain / pepsin A


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 25 g in 100 g TOPICAL STICK [Pit Boss Antiperspirant and Deodorant]


name: {84 (cabozantinib 20 MG Oral Capsule) / 28 (cabozantinib 80 MG Oral Capsule) } Pack


name: aluminum magnesium silicate / calcium carbonate / sodium bicarbonate


name: {28 (cabozantinib 20 MG Oral Capsule) / 28 (cabozantinib 80 MG Oral Capsule) } Pack


name: TITANIUM DIOXIDE 8.3 g in 100 g TOPICAL CREAM [Too Faced BB Creme Complete Coverage Make-Up SPF-20 CREAM GLOW]


name: eucalyptol / menthol / sodium fluoride / thymol


name: OCTINOXATE 7.5 g in 100 g / TITANIUM DIOXIDE 3.67 g in 100 g TOPICAL LIQUID [Sheer Defense Tinted Moisturizer Broad Spectrum SPF 15 MD 70 Merle Norman]


name: OCTINOXATE 7.5 g in 100 g / TITANIUM DIOXIDE 4.19 g in 100 g TOPICAL LIQUID [Sheer Defense Tinted Moisturizer Broad Spectrum SPF 15 M50 Merle Norman]


name: OCTINOXATE 7.5 g in 100 g / TITANIUM DIOXIDE 4.79 g in 100 g TOPICAL LIQUID [Sheer Defense Tinted Moisturizer SPF 15 ML 30 Merle Norman]


name: OCTINOXATE 7.5 g in 100 g / TITANIUM DIOXIDE 5.02 g in 100 g TOPICAL LIQUID [Sheer Defense Tinted Moisturizer SPF15 L20 Merle Norman]


name: TITANIUM DIOXIDE 24.8 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [3LAB PERFECT Lite Sunscreen SPF 30 Broad Spectrum]


name: OCTOCRYLENE 1 g in 100 g / AVOBENZONE 0.5 g in 100 g TOPICAL LOTION [HAWAIIAN TROPIC]


name: AVOBENZONE 2.5 g in 100 g / OCTOCRYLENE 8 g in 100 g / OXYBENZONE 3.5 g in 100 g TOPICAL LOTION [Banana Boat]


name: ZINC OXIDE 5.0 g in 100 g / OXYBENZONE 3.0 g in 100 g / OCTINOXATE 7.5 g in 100 g TOPICAL CREAM [Cellular Day Defense Firming SPF 25]


name: HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL TOPICAL CREAM [3LAB PERFECT Sunscreen SPF 50 Plus Broad Spectrum]


name: Other Government (Federal, State, Local not specified)


name: No Typology Code available for payment source


name: Other specified but not otherwise classifiable (includes Hospice - Unspecified plan)


name: NO PAYMENT from an Organization/Agency/Program/Private Payer Listed


name: MANAGED CARE, UNSPECIFIED (to be used only if one can't distinguish public from private)


name: Managed Care (private) or private health insurance (indemnity), not otherwise specified


name: Private health insurance--other commercial Indemnity


name: Medicare supplemental policy (as second payer)


name: Self-insured (ERISA) Administrative Services Only (ASO) plan


name: Federal, State, Local not specified - Other


name: Federal, State, Local not specified - FFS


name: Federal, State, Local not specified - not specified managed care


name: Federal, State, Local not specified - POS


name: Federal, State, Local not specified - PPO


name: Federal, State, Local not specified - HMO


name: Federal, State, Local not specified managed care


name: Local, not otherwise specified (other local, county)


name: State, not otherwise specified (other state)


name: Specific state programs (list/ local code)


name: State SCHIP program (codes for individual states)


name: Children of Women Vietnam Veterans (CWVV)


name: Civilian Health and Medical Program for the VA (CHAMPVA)


name: Contract Nursing Home/Community Nursing Home


name: Foreign Fee/Foreign Medical Program (FMP)


name: Indirect Care-Care provided outside VA facilities


name: Direct Care-Care provided in VA facilities


name: Uniformed Services Family Health Plan (USFHP) -- HMO


name: OTHER GOVERNMENT (Federal/State/Local) (excluding Department of Corrections)


name: Medicaid PCCM (Primary Care Case Management)


name: OCTISALATE 5 g in 100 g / TITANIUM DIOXIDE 23 g in 100 g TOPICAL PASTE [Le Velvet Film Makeup Refill SPF 15]


name: Octinoxate 75 mg in 1 mL / Octisalate 20 mg in 1 mL / Oxybenzone 50 mg in 1 mL / Titanium Dioxide 21 mg in 1 mL TOPICAL CREAM, AUGMENTED [Jurlique Sun Sunscreen SPF 30]


name: {84 (cabozantinib 20 MG Oral Capsule) } Pack


name: OCTINOXATE 75 mg in 1 g / ZINC OXIDE 105 mg in 1 g TOPICAL LOTION [NU-DERM SUN SHIELD BROAD SPECTRUM SPF 50 MATTE SUNSCREEN]


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Chateal 28 Day]


name: OCTINOXATE 6 g in 100 mL / OCTISALATE 4.5 g in 100 mL / AVOBENZONE 1.5 g in 100 mL TOPICAL CREAM [TREAT AND TINT SKIN PERFECTING BB SPF 30]


name: OCTINOXATE 75 mg in 1 mL / ZINC OXIDE 10.1 mg in 1 mL TOPICAL CREAM [Advanced Anti-Aging Eye Broad Spectrum SPF 37 Supergoop]


name: PERGOLIDE MESYLATE 1 g in 1 g NOT APPLICABLE POWDER


name: TITANIUM DIOXIDE 5 g in 100 mL / ZINC OXIDE 5 g in 100 mL TOPICAL CREAM [Too Faced Tinted Beauty Balm SPF-20]


name: TITANIUM DIOXIDE 121.6 mg in 1 mL TOPICAL CREAM [3LAB PERFECT BB SPF 40 Broad Spectrum 01]


name: TITANIUM DIOXIDE 77.2 mg in 1 mL TOPICAL CREAM [3LAB PERFECT BB SPF 40 Broad Spectrum 03]


name: TYLOSIN TARTRATE 1 g in 1 g NOT APPLICABLE POWDER


name: arginine / folic acid / piperine / vitamin B12 / vitamin B6


name: AVOBENZONE 25 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OXYBENZONE 20 mg in 1 mL TOPICAL CREAM [Facial Boosting Broad Spectrum SPF 15 Jafra]


name: XYLAZINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER [Xylazine hydrochloride]


name: CATHERIZATION SET,FOLEY 18FR KENDALL #6950LF


name: CATHETER,FOLEY 2-WAY 20FR 30CC BARD #1768SI20


name: LARYNGEAL PROSTHESIS CLEANING BRUSH,PROVOX 12-18MM #7225


name: LARYNGEAL PROSTHESIS FLUSHING DEVICE,PROVOX #8109


name: PRODIGY AUTOCODE TALKING (GLUCOSE) METER


name: {1 (acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack


name: acetaminophen / caffeine / chlorpheniramine / guaifenesin / N-methylephedrine


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 14.4 g in 75 g TOPICAL STICK [Sport Anti-Perpirant Sportstick Molton Brown London]


name: TITANIUM DIOXIDE 3.42 g in 30 mL TOPICAL CREAM [BB Cream]


name: Titanium Dioxide .30 g in 50 mL / OCTINOXATE 1.80 g in 50 mL / OCTOCRYLENE 2.25 g in 50 mL TOPICAL CREAM [Melafadin Day Protection]


name: FLORBETAPIR F18, DIAGNOSTIC, PER STUDY DOSE, UP TO 10 MILLICURIES


name: OCTOCRYLENE 10 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION [Cetaphil]


name: Borderline symptom list - behavior supplement


name: Metanephrine, Normetanephrine, 3-Methoxytyramine & Creatinine panel


name: Extrinsic coagulation factor activity 4 panel


name: Intrinsic coagulation factor activity 4 panel


name: HIV integrase inhibitor susceptibility panel


name: Guidance for repair of central venous catheter without port or pump


name: Guidance for repair of central venous catheter with port or pump


name: Guidance for substance removal of central venous catheter pericatheter obstruction


name: Guidance for substance removal of central venous catheter lumen obstruction


name: Guidance for percutaneous device removal of nephrostomy tube


name: Vital signs with smoking status and pain scale


name: WT1 gene exon 1+2 transcript/control transcript


name: Beta 2 glycoprotein 1 Ab.IgG & IgM panel


name: Area of identified wound bed appearance/Area of wound bed


name: t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript


name: t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript


name: NPM1 gene.c.956dupTCTG transcript/control transcript


name: NPM1 gene.c.960insCATG transcript/control transcript


name: NPM1 gene.c.960insCCTG transcript/control transcript


name: t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript


name: Platelet function.collagen+Adenosine diphosphate induced & EPINEPHrine induced panel


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript


name: t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript


name: Pediatric systolic blood pressure percentile


name: Pediatric diastolic blood pressure percentile


name: Stalwart of Standardization + Vocabulary Curator Virtuoso


name: Chlamydia trachomatis & Neisseria gonorrhoeae DNA panel


name: Evaluation of mental and physical incapacity certificate


name: Bilirubin excess & oxyhemoglobin & methemoglobin & xanthochromia & albumin quotient panel


name: t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript


name: Parents' evaluation of developmental status - developmental milestones


name: Smudge Cells to Leukocytes Ratio Measurement


name: Functional assessment of cancer therapy for patients with prostate cancer questionnaire - version 4


name: Now we would like to know in addition the quality of your overall personal state in the course of the last W


name: Pediatric - patients with brain cancer - parent_child questionnaire - version 1


name: Pediatric - patients with brain cancer - parent_adolescent questionnaire - version 1


name: Pediatric - patients with brain cancer - child questionnaire - version 2


name: Pediatric - patients with brain cancer - adolescent questionnaire - version 2


name: Pediatric - functional assessment of anorexia cachexia questionnaire - 10 items - version 2


name: Pediatric - functional assessment of anorexia cachexia - parent_child questionnaire - version 1


name: Pediatric - functional assessment of anorexia cachexia - parent_adolescent questionnaire - version 1


name: Pediatric - functional assessment of anorexia cachexia - child questionnaire - version 1


name: Pediatric - functional assessment of anorexia cachexia - adolescent questionnaire - version 1


name: Functional assessment of HIV infection questionnaire - version 4


name: Functional assessment of multiple sclerosis questionnaire - version 4


name: Functional assessment of incontinence therapy - urinary questionnaire - version 4


name: Functional assessment of incontinence therapy - fecal questionnaire - version 4


name: Functional assessment of cancer therapy for patients with thrombocytopenia questionnaire - 18 items - version 4


name: Functional assessment of cancer therapy for patients with thrombocytopenia questionnaire - 11 items - version 4


name: Functional assessment of cancer therapy for patients with cognitive function issues questionnaire - version 3


name: Functional assessment of cancer therapy for patients with bone pain questionnaire


name: Functional assessment of cancer therapy for patients with lymphedema questionnaire - version 4


name: Functional assessment of cancer therapy for patients with anemia - fatigue questionnaire - version 4


name: Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire


name: Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire


name: Functional assessment of cancer therapy for patients receiving biologic response modifiers questionnaire - version 4


name: Functional assessment of cancer therapy for patients undergoing bone marrow transplantation questionnaire - version 4


name: Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - 4 items - version 4


name: Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - 13 items - version 4


name: Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - 12 items - version 4


name: Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - version 4


name: Functional assessment of cancer therapy for patients with EGFRI inhibitors questionnaire - 18 items


name: Functional assessment of cancer therapy for patients receiving enteral feeding questionnaire - version 1


name: National comprehensive cancer network - prostate symptom index questionnaire - 17 items


name: National comprehensive cancer network - kidney symptom index questionnaire - 19 items


name: National comprehensive cancer network - hepatibiliary symptom index questionnaire - 18 items


name: National comprehensive cancer network - breast symptom index questionnaire - 16 items


name: National comprehensive cancer network - brain symptom index questionnaire - 24 items


name: National comprehensive cancer network - bladder symptom index questionnaire - 18 items


name: Functional assessment of non-life threatening conditions questionnaire - version 4


name: Functional assessment of cancer therapy - general population questionnaire - version 4


name: Functional assessment of cancer therapy for patients with vulva cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with ovarian cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with nasopharyngeal cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patient with multiple myeloma questionnaire - version 4


name: Functional assessment of cancer therapy for patients with melanoma questionnaire - version 4


name: Functional assessment of cancer therapy for patients with non-hodgkins lymphoma questionnaire - version 4


name: Functional assessment of cancer therapy for patients with leukemia questionnaire - version 4


name: Functional assessment of cancer therapy for patients with lung cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with hepatobiliary cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with head and neck cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with gastric cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with endometrial cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with cancer of the cervix questionnaire - version 4


name: Functional assessment of cancer therapy for patients with cancer in the central nervous system questionnaire - version 4


name: Functional assessment of cancer therapy for patients with colorectal cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with brain cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with bladder cancer questionnaire - version 4


name: Functional assessment of cancer therapy for patients with breast cancer questionnaire - version 4


name: Functional Assessment of Cancer Therapy-General Version 4 Questionnaire


name: Functional assessment of cancer therapy for patients with neutropenia questionnaire - version 4


name: National comprehensive cancer network - head and neck symptom index questionnaire - 22 items


name: National comprehensive cancer network - colorectal symptom index questionnaire - 19 items


name: Macrophage to Leukocyte Ratio measurement


name: National comprehensive cancer network - ovarian symptom index questionnaire - 18 items


name: National comprehensive cancer network - lymphoma symptom index questionnaire - 18 items


name: National comprehensive cancer network - lung symptom index questionnaire - 17 items


name: HEDIS 2012, 2013 Tests used in early prenatal care - ABO & Rh (PPC-C)


name: During your leisure time, have you been regularly, more than once a W, exposed to loud sound or noise, so that you have to shout to make yourself heard by someone who was more than 1 meter away from you


name: Does your child now take vitamins with fluoride in them or any other kind of fluoride tablets, drops or supplements


name: Does anyone else in the family use toothpaste with fluoride


name: For whom did you work for at your main job or business


name: Rate pain severity using verbal descriptor scale


name: Lactate dehydrogenase.plr fld/Lactate dehydrogenase.serum


name: Neutrophil oxidative burst stimulated/unstimulated


name: (Acer negundo+Quercus alba+Ulmus americana+Populus deltoides+Carya illinoinensis) Ab.IgE.RAST class


name: Setomelanomma rostrata Ab.IgE.RAST class


name: Severity of pain on average over the past Mo:Find:1Mo:^Patient:Ord:Reported


name: Multisection^W contrast PO+WO & W contrast IV:Find:Pt:Abdomen+Pelvis:Doc:MR


name: Staphylococcus aureus enterotoxin C sec gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Staphylococcus aureus enterotoxin D sed gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: SLC40A1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Metanephrine, Normetanephrine, 3-Methoxytyramine & Creatinine panel:-:Pt:Urine:-


name: Extrinsic coagulation factor activity 4 panel:-:Pt:PPP:-


name: Intrinsic coagulation factor activity 4 panel:-:Pt:PPP:-:Coag


name: Guidance for vascular sclerotherapy:Find:Pt:Extremity.left>Extremity vein:Doc:US


name: Guidance for vascular sclerotherapy:Find:Pt:Extremity.right>Extremity vein:Doc:US


name: Guidance for vascular sclerotherapy:Find:Pt:Extremity.left>Extremity veins:Doc:US


name: Guidance for vascular sclerotherapy:Find:Pt:Extremity.right>Extremity veins:Doc:US


name: Streptococcus agalactiae:PrThr:Pt:Vag+Rectum:Ord:Organism specific culture


name: Hepatitis D virus genotype:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Insulin^4.5H post 75 g glucose PO:ACnc:Pt:Ser/Plas:Qn


name: Creatine kinase.aberrant band/Creatine kinase.total:CFr.DF:Pt:Ser/Plas:Qn:Electrophoresis


name: HIV integrase inhibitor susceptibility panel:-:Pt:Isolate:-:Genotyping


name: HIV integrase inhibitor susceptibility panel:-:Pt:Isolate:-:Phenotyping


name: Guidance for trigger point injection:Find:Pt:XXX>Muscle:Doc:RF


name: Guidance for repair of central venous catheter without port or pump:Find:Pt:XXX>Vein:Doc:RF.angio


name: Guidance for repair of central venous catheter with port or pump:Find:Pt:XXX>Vein:Doc:RF.angio


name: Guidance for removal of tunneled central venous catheter:Find:Pt:XXX>Vein:Doc:RF


name: Guidance for removal of central venous catheter^W contrast IV:Find:Pt:XXX>Vein:Doc:RF.angio


name: Guidance for substance removal of central venous catheter pericatheter obstruction:Find:Pt:XXX>Vein:Doc:RF.angio


name: Guidance for substance removal of central venous catheter lumen obstruction:Find:Pt:XXX>Vein:Doc:RF.angio


name: Guidance for percutaneous replacement of drainage catheter:Find:Pt:Abdomen>Biliary ducts+Gallbladder:Doc:RF


name: Guidance for percutaneous device removal of nephrostomy tube^W contrast:Find:Pt:Abdomen>Kidney.bilateral:Doc:RF


name: Guidance for denervation:Find:Pt:Chest>Spine.thoracic intercostal nerve:Doc:RF


name: Guidance for denervation:Find:Pt:Abdomen>Spine.lumbar facet joint:Doc:RF


name: Guidance for denervation:Find:Pt:Neck>Spine.cervical facet joint:Doc:RF


name: Guidance for denervation:Find:Pt:XXX>Spine facet joint:Doc:RF


name: Guidance for denervation:Find:Pt:XXX>Peripheral nerve:Doc:RF


name: Guidance for removal of peripherally-inserted central venous catheter:Find:Pt:XXX>Vein:Doc:RF.angio


name: Guidance for vascular sclerotherapy:Find:Pt:Extremity.bilateral>Extremity vein:Doc:US


name: Guidance for vascular sclerotherapy:Find:Pt:Extremity.bilateral>Extremity veins:Doc:US


name: Guidance for laser ablation:Find:Pt:Extremity.left>Extremity vein:Doc:US


name: Guidance for laser ablation:Find:Pt:Extremity.right>Extremity vein:Doc:US


name: Guidance for ambulatory phlebectomy:Find:Pt:Extremity.left>Extremity vein:Doc:US


name: Guidance for ambulatory phlebectomy:Find:Pt:Extremity.right>Extremity vein:Doc:US


name: Multisection^W contrast IV+W air contrast PR:Find:Pt:Abdomen+Pelvis>Colon+Rectum:Doc:CT


name: Glutamate decarboxylase 65 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: p-ANCA formalin resistant Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: p-ANCA formalin sensitive Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: Infections present &or treated during this pregnancy for live birth:Prid:Pt:^Patient:Nom:US standard certificate of live birth


name: CHEK2 gene.c.470C>T & 1100delC:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Vital signs with smoking status and pain scale:-:Pt:^Patient:-:VSP


name: CYP2B6 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: WT1 gene exon 1+2 transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Homocyst(e)ine^6H post dose methionine - post CFst:SCncDiff:Pt:Ser/Plas:Qn


name: Homocyst(e)ine^6H post dose methionine:SCnc:Pt:Ser/Plas:Qn


name: Oval fat bodies (globules):Naric:Pt:Stool:Qn:Microscopy.light.LPF


name: Beta 2 glycoprotein 1 Ab.IgG & IgM panel:-:Pt:Ser:-


name: TF gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Candida sp 6 panel:-:Pt:Vag:-:Probe.amp.tar


name: Bacterial vancomycin resistance vanB gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Cell count panel:-:Pt:Vitr fld:-:Manual count


name: Cell count & Differential panel:-:Pt:Vitr fld:-:Manual count


name: Hepatitis C virus Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: Area of identified wound bed appearance/Area of wound bed:ArArea:Pt:Wound.base:Qn


name: t(11;14)(q13;q32)(CCND1,IGH) fusion transcript:PrThr:Pt:Bone mar:Ord:Molgen


name: Influenza virus A+B Ag:PrThr:Pt:Nose:Ord:IA.rapid


name: Influenza virus A & B Ag:Prid:Pt:Nose:Nom:IA.rapid


name: Influenza virus A & B Ag:Prid:Pt:Nose:Nom:IF


name: Influenza virus A & B Ag:Prid:Pt:XXX:Nom:IA.rapid


name: Overall quality of life over the past Mo:Find:1Mo:^Patient:Ord:Reported


name: Overall physical well being over the past Mo:Find:1Mo:^Patient:Ord:Reported


name: Overall emotional well being over the past 1Mo:Find:1Mo:^Patient:Ord:Reported


name: Social interaction with other people - family, friends, or others - over the past Mo:Find:1Mo:^Patient:Ord:Reported


name: Level of fatigue on average over the past Mo:Find:1Mo:^Patient:Ord:Reported


name: Round cells:NCnc:Pt:Prostatic fld:Qn:Manual count


name: Neutrophils/Round cells:NFr:Pt:Prostatic fld:Qn:Manual count


name: Monocytes/Round cells:NFr:Pt:Prostatic fld:Qn:Manual count


name: NPM1 gene.c.960insCCTG transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: NPM1 gene.c.956dupTCTG transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: NPM1 gene.c.960insCATG transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: Nucleated cells/Round cells:NFr:Pt:Prostatic fld:Qn:Manual count


name: Anucleated bodies/Round cells:NFr:Pt:Prostatic fld:Qn:Manual count


name: Nucleated cells/Round cells:NFr:Pt:Semen:Qn:Manual count


name: Anucleated bodies/Round cells:NFr:Pt:Semen:Qn:Manual count


name: Functional shunt volume^^adjusted to patient's actual temperature:VFr:Pt:BldA:Qn


name: Functional shunt volume^^adjusted to patient's actual temperature:VFr:Pt:BldA+BldMV:Qn


name: Centromere protein A Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: RNA polymerase III RP11 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: RNA polymerase III RP155 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: Platelet-derived growth factor receptor Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: NPM1 gene.c.956dupTCTG transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: NPM1 gene.c.960insCATG transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: NPM1 gene.c.960insCCTG transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Brucella sp Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn


name: Brucella sp Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn


name: Wound tunneling & undermining panel:-:Pt:Wound:-


name: Drainage amount from device:Vol:Pt:Wound.exudate:Qn


name: Days in therapeutic INR range/Days INR result determined:Ratio:Pt:^Patient:Qn


name: Rh immune globulin expiration:TmStp:Pt:^BPU:Qn


name: (Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Dedication to Excellence + Inspiration to All:Hx:Pt:^Patient:Nar:JP


name: t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Amylase & triacylglycerol lipase panel:-:Pt:Ser/Plas:Qn


name: Platelet function.collagen+Adenosine diphosphate induced & EPINEPHrine induced panel:-:Pt:Bld:-


name: Views for motility^W radioopaque markers:Find:Pt:Abdomen:Doc:XR


name: Multisection^WO & W contrast IV:Find:Pt:Chest+Abdomen+Pelvis:Doc:CT


name: Multisection for pulmonary embolus:Find:Pt:Chest>Pulmonary arteries:Doc:CT


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Abdomen>Small bowel:Doc:CT


name: Guidance for endoscopy^WO & W contrast IV:Find:Pt:Abdomen>Liver+Biliary ducts+Pancreas:Doc:MR


name: Multisection^W contrast PO+WO contrast IV:Find:Pt:Abdomen+Pelvis:Doc:MR


name: Multisection^W contrast PR+at rest+maximal sphincter contraction+during straining+during defecation:Find:Pt:Pelvis:Doc:MR


name: Multisection endorectal^WO & W contrast IV:Find:Pt:Pelvis:Doc:MR


name: Multisection^W contrast IV:Find:Pt:Lower extremity.left>Toes:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Toes:Doc:MR


name: Multisection^W contrast IV:Find:Pt:Lower extremity.right>Toes:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Toes:Doc:MR


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Epstein Barr virus nuclear 1 Ab.IgG & IgM:ColorRto:Pt:Ser/Plas:Nom:IA.rapid


name: Changes in sleeping patterns - follow up:-:Pt:^Patient:-:M3


name: Changes in appetite - follow up:-:Pt:^Patient:-:M3


name: Discharge disposition - long term care hospital:Type:Pt:^Patient:Nom:CARE


name: Influenza virus A matrix protein segment sequence identifier:ID:Pt:Isolate:Nom:Sequencing


name: Influenza virus A neuraminidase segment sequence identifier:ID:Pt:Isolate:Nom:Sequencing


name: Quality of life score:Score:Pt:^Patient:Qn:KCCQ


name: Date tetanus vaccine given:Date:Pt:^Patient:Qn:RHEA


name: Treated for syphillis:Find:Pt:^Significant other:Ord:RHEA


name: Tested for HIV:Find:Pt:^Significant other:Ord:RHEA


name: HIV results shared with partner:Find:Pt:^Patient:Ord:RHEA


name: Given iron and folic acid:Find:Pt:^Patient:Ord:RHEA


name: Given pyrimethamine sulfadoxine - starting at 4th Mo:Find:Pt:^Patient:Ord:RHEA


name: Given a mosquito net:Find:Pt:^Patient:Ord:RHEA


name: Facility recommended for birth:Find:Pt:^Patient:Nom:RHEA


name: Glucose tolerance 2H panel:-:-:Ser/Plas:Qn


name: Ofloxacin 1.5 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Pediatric systolic blood pressure percentile:Prctl:Pt:^Patient:Qn:Per age, sex and height


name: Pediatric diastolic blood pressure percentile:Prctl:Pt:^Patient:Qn:Per age, sex and height


name: Inulin renal clearance/1.73 sq M:ArVRat:Stdy:Urine+Ser/Plas:Qn


name: Rwandan maternal screening panel:-:Pt:^Patient:-:RHEA


name: Last born child vital status:Find:Pt:^Patient:Ord:RHEA


name: Arrived at clinic with partner:Find:Pt:^Patient:Ord:RHEA


name: Stalwart of Standardization + Vocabulary Curator Virtuoso:Hx:Pt:^Patient:Nar:KM


name: Chlamydia trachomatis & Neisseria gonorrhoeae DNA panel:-:Pt:XXX:-


name: Prostate specific Ag.free/Prostate specific Ag.total:MFr.DF:Pt:Ser/Plas:Qn


name: Streptococcus pyogenes exotoxin B speB gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Evaluation of mental and physical incapacity certificate:Find:Pt:{Setting}:Doc:{Role}


name: Influenza virus A Ab.IgA:ACnc:Pt:Ser:Qn:IA


name: Influenza virus B Ab.IgA:ACnc:Pt:Ser:Qn:IA


name: Bilirubin excess & oxyhemoglobin & methemoglobin & xanthochromia & albumin quotient panel:-:Pt:Ser+CSF:-


name: Neonatal vital status at delivery:Find:Pt:^Patient:Ord:RHEA


name: Post-natal maternal vital status:Find:Pt:^Patient:Ord:RHEA


name: Acute & chronic leukemia fusion transcript per control transcript panel:-:Pt:Bld/Tiss:-:Molgen


name: t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Neutrophils.band form/Leukocytes:NFr.DF:Pt:Body fld:Qn:Manual count


name: Mesothelial cells/Leukocytes:NFr.DF:Pt:Body fld:Qn:Manual count


name: Unidentified cells/Leukocytes:NFr.DF:Pt:Body fld:Qn:Manual count


name: Unspecified cells/Leukocytes:NFr.DF:Pt:Body fld:Qn:Manual count


name: Plasma cells/Leukocytes:NFr.DF:Pt:Body fld:Qn:Manual count


name: Leukocytes other/Leukocytes:NFr.DF:Pt:Periton fld:Qn:Manual count


name: Mononuclear cells/Leukocytes:NFr.DF:Pt:Periton fld:Qn:Manual count


name: Mesothelial cells/Leukocytes:NFr.DF:Pt:Periton fld:Qn:Manual count


name: Leukocytes other/Leukocytes:NFr.DF:Pt:Plr fld:Qn:Manual count


name: Mononuclear cells/Leukocytes:NFr.DF:Pt:Plr fld:Qn:Manual count


name: Mesothelial cells/Leukocytes:NFr.DF:Pt:Plr fld:Qn:Manual count


name: Leukocytes other/Leukocytes:NFr.DF:Pt:Pericard fld:Qn:Manual count


name: Mesothelial cells/Leukocytes:NFr.DF:Pt:Pericard fld:Qn:Manual count


name: Insulin-like growth factor-II.high molecular weight:MCnc:Pt:Ser/Plas:Qn


name: SNRPN gene 15q11 deletion+duplication:Prid:Pt:Bld/Tiss:Nom:FISH


name: Leukocytes other/Leukocytes:NFr.DF:Pt:Synv fld:Qn:Manual count


name: Mononuclear cells/Leukocytes:NFr.DF:Pt:Synv fld:Qn:Manual count


name: Department of Health and Human Services, Affordable Care Act Section 4302


name: Multisection limited for physiologic artery study


name: Multisection for physiologic artery study


name: CYP2D6 gene & CYP2C19 gene targeted mutation analysis panel


name: Serum/Plasma+Synovial fluid (Joint fluid)


name: VR-12 Mental component summary score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Physical component summary score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Mental component summary score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Physical component summary score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Physical functioning score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Role physical score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Bodily pain score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 General health score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Vitality score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Social functioning score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Role emotion score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Mental health score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-12 Physical functioning score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-12 Role physical score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-12 Bodily pain score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-12 General health score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-12 Vitality score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-12 Social functioning score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-12 Role emotion score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-12 Mental health score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 Mental component summary score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Physical component summary score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Physical functioning score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Role physical score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Bodily pain score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 General health score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Vitality score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Social functioning score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Role emotion score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Mental health score - orthogonal method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Physical functioning score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 Role physical score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 Bodily pain score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 General health score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 Vitality score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 Social functioning score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 Role emotion score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 Mental health score - orthogonal method:Score:Pt:^Patient:Qn:VR


name: VR-36 Mental component summary score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Physical component summary score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Physical functioning score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Role physical score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Bodily pain score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 General health score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Vitality score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Social functioning score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Role emotion score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Mental health score - oblique method:Tscore:Pt:^Patient:Qn:VR


name: VR-36 Physical functioning score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 Role physical score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 Bodily pain score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 General health score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 Vitality score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 Social functioning score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 Role emotion score - oblique method:Score:Pt:^Patient:Qn:VR


name: VR-36 Mental health score - oblique method:Score:Pt:^Patient:Qn:VR


name: Veterans RAND health survey - 12 item:-:Pt:^Patient:-:VR


name: Veterans RAND health survey - 36 item:-:Pt:^Patient:-:VR


name: Does your health now limit you in vigorous activities, such as running, lifting heavy objects, participating in strenuous sports:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in moderate activities, such as moving a table, pushing a vacuum cleaner, bowling or playing golf:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in lifting or carrying groceries:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in climbing several flights of stairs:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in climbing one flight of stairs:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in bending, kneeling, stooping:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in walking more than a mile:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in walking several blocks:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in walking one block:Find:Pt:^Patient:Ord:VR


name: Does your health now limit you in bathing or dressing yourself:Find:Pt:^Patient:Ord:VR


name: As a result of your physical health, have you cut down the amount of time you spent on work or other activities in the past 4W:Find:4W:^Patient:Ord:VR


name: As a result of your physical health, have you accomplished less than you would like in the past 4W:Find:4W:^Patient:Ord:VR


name: As a result of your physical health, were you limited in the kind of work in the past 4W:Find:4W:^Patient:Ord:VR


name: As a result of your physical health, have you had difficulty performing the work or other activities - for example, it took extra effort in the past 4W:Find:4W:^Patient:Ord:VR


name: As a result of any emotional problems, have you cut down the amount of time you spent on work or other activities in the past 4W:Find:4W:^Patient:Ord:VR


name: As a result of any emotional problems, have you accomplished less than you would like in the past 4W:Find:4W:^Patient:Ord:VR


name: As a result of any emotional problems, you didn't do work or other activities as carefully as usual in the past 4W:Find:4W:^Patient:Ord:VR


name: During the past 4W, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors or groups:Find:4W:^Patient:Ord:VR


name: How much bodily pain have you had during the past 4W:Find:4W:^Patient:Ord:VR


name: During the past 4W, how much did pain interfere with your normal work - including both work outside the home and house work:Find:4W:^Patient:Ord:VR


name: Did you feel full of pep during the past 4W:Find:4W:^Patient:Ord:VR


name: Have you been a very nervous person during the past 4W:Find:4W:^Patient:Ord:VR


name: Have you felt so down in the dumps that nothing could cheer you up during the past 4W:Find:4W:^Patient:Ord:VR


name: Have you felt calm and peaceful during the past 4W:Find:4W:^Patient:Ord:VR


name: Did you have a lot of energy during the past 4W:Find:4W:^Patient:Ord:VR


name: I expect my health to get worse:Find:Pt:^Patient:Ord:VR


name: My health is excellent:Find:Pt:^Patient:Ord:VR


name: Compared to one Y ago, how would you rate your physical health in general now:Find:Pt:^Patient:Ord:VR


name: Compared to one Y ago, how would you rate your emotional problems, such as feeling anxious,depressed or irritable, now:Find:Pt:^Patient:Ord:VR


name: Have you felt downhearted and blue during the past 4W:Find:4W:^Patient:Ord:VR


name: Did you feel worn out during the past 4W:Find:4W:^Patient:Ord:VR


name: Have you been a happy person during the past 4W:Find:4W:^Patient:Ord:VR


name: Did you feel tired during the past 4W:Find:4W:^Patient:Ord:VR


name: During the past 4W, how much of the time has your physical health or emotional problems interfered with your social activities - like visiting with friends, relatives, etc.:Find:4W:^Patient:Ord:VR


name: I seem to get sick a lot easier than other people:Find:Pt:^Patient:Ord:VR


name: I am as healthy as anyone I know:Find:Pt:^Patient:Ord:VR


name: Ages and stages questionnaires:-:Pt:^Patient:-:ASQ


name: Assistive listening device, transmitter microphone, any type


name: Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type


name: Assistive listening device, personal fm/dm transmitter assistive listening device


name: Assistive listening device, personal fm/dm receiver, not otherwise specified


name: Assistive listening device, personal blue tooth fm/dm receiver


name: Assistive listening device, personal fm/dm, direct audio input receiver


name: Assistive listening device, personal fm/dm, ear level receiver


name: Assistive listening device, personal fm/dm neck, loop induction receiver


name: Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type


name: Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type


name: Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month


name: Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient


name: Phakic intraocular lens for correction of refractive error


name: Treatment planning and care coordination management for cancer, established patient with a change of regimen


name: Treatment planning and care coordination management for cancer, initial treatment


name: Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies


name: Tension ring, for vacuum erection device, any type, replacement only, each


name: Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s)


name: Injection, peginesatide, 0.1 mg (for esrd on dialysis)


name: Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes


name: Mapcp demonstration - physician incentive pool


name: Mapcp demonstration - community health teams


name: Mapcp demonstration - state provided services


name: National committee for quality assurance - level 3 medical home


name: National committee for quality assurance - level 2 medical home


name: Most recent assessment of adequacy of volume management documented


name: Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented


name: Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment


name: Low dose rate (ldr) prostate brachytherapy services, composite rate


name: Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen


name: Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist


name: Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)


name: Molecular pathology procedure; physician interpretation and report


name: Power wheelchair component, actuator, replacement only


name: Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk


name: Non-ophthalmic fluorescent vascular angiography


name: Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)


name: Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel


name: Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel


name: Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)


name: Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel


name: Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)


name: Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch


name: Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)


name: Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch


name: Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each


name: Solutions and Drugs (CMS Temporary Codes)


name: {1 (480 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) / 1 (2000 ML) (polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution) } Pack [Suclear]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / OXYBENZONE 5 g in 100 mL TOPICAL CREAM [Sunscreen Broad Spectrum SPF 50 Jafra]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / AVOBENZONE 20 mg in 1 mL TOPICAL CREAM [Solutions Ageless Results Day]


name: OCTINOXATE 75 mg in 1 g TOPICAL LIPSTICK [Beyond Color Plumping Lipcolor]


name: AVOBENZONE 3 g in 75 mL / OCTINOXATE 7.5 g in 75 mL / OCTISALATE 5 g in 75 mL / OXYBENZONE 2 g in 75 mL TOPICAL JELLY [Hand Complex Broad Spectrum SPF 15 Jafra]


name: TITANIUM DIOXIDE 66.2 mg in 1 g / OCTINOXATE 25 mg in 1 g TOPICAL CREAM [Anew Age-Transforming Concealer]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 40 mg in 1 mL TOPICAL LOTION [Anew Age-Transforming Foundation]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 20 mg in 1 mL TOPICAL LOTION [Solutions A.M. Total Radiance]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 20 mg in 1 mL / HOMOSALATE 20 mg in 1 mL TOPICAL CREAM [Anew Rejuvenate 24 hour Eye Moisturizer]


name: OCTINOXATE 71.1 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OXYBENZONE 30 mg in 1 mL / AVOBENZONE 25 mg in 1 mL TOPICAL LOTION [Clearskin Professional Oil Free]


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL CREAM [SUPER CREME SOLAIRE CORPS Body sun care SPF 15]


name: OCTINOXATE 2.6 g in 35 g / TITANIUM DIOXIDE 15.3 g in 35 g TOPICAL LIQUID [Sheer Defense Tinted Moisturizer SPF 15 ML 40 Merle Norman]


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Estarylla 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Estarylla 28 Day]


name: AVOBENZONE 30 mg in 1 g / OCTINOXATE 50 mg in 1 g / OCTISALATE 50 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL CREAM [SUNLEYA Age minimizing sun care SPF 15]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL CREAM [SUNLEYA Age minimizing sun care SPF 50 plus]


name: OCTINOXATE 71.1 mg in 1 g / OCTISALATE 47.5 mg in 1 g / OXYBENZONE 40.0 mg in 1 g / AVOBENZONE 28.5 mg in 1 g TOPICAL CREAM [Anew Reversalist Day Renewal]


name: AVOBENZONE 20 mg in 1 g / OCTINOXATE 50 mg in 1 g / OCTISALATE 30 mg in 1 g TOPICAL CREAM [SISLEYA Global Anti-Age Hand care SPF 15]


name: TITANIUM DIOXIDE 5.76 g in 100 g / ZINC OXIDE 2.94 g in 100 g TOPICAL CREAM [SUPER BB 10-IN-1 BEAUTY BALM CREAM SPF 30]


name: ENROFLOXACIN 1 g in 1 g NOT APPLICABLE POWDER


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Gildagia]


name: TITANIUM DIOXIDE 54 mg in 1 mL / ZINC OXIDE 108 mg in 1 mL TOPICAL LOTION [Blue Lizard Sensitive Sunscreen]


name: AVOBENZONE 3.0 g in 100 mL / ENSULIZOLE 1.0 g in 100 mL / OCTISALATE 5.0 g in 100 mL TOPICAL LOTION [Ponds Luminous Moisture Day SPF 15]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL SPRAY [Sunscreen Mist Broad Spectrum SPF 30 Supergoop]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL OINTMENT [Softlips Vanilla]


name: LIDOCAINE 10 g in 100 g TOPICAL SPRAY [Promescent]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL STICK [Softlips Pearl]


name: neomycin / nystatin / thiostrepton / triamcinolone


name: Decreased cholesterol diet (regime/therapy)


name: N-methyl-D-aspartate Receptor Antagonist [EPC]


name: Angiotensin Converting Enzyme Inhibitor [EPC]


name: Nonsteroidal Anti-inflammatory Drug [EPC]


name: Human Immunodeficiency Virus Protease Inhibitor [EPC]


name: Gonadotropin Releasing Hormone Antagonist [EPC]


name: Nucleoside Reverse Transcriptase Inhibitor


name: Non-nucleoside Reverse Transcriptase Inhibitor


name: Inactivated Japanese Encephalitis Virus Vaccine [EPC]


name: Serotonin and Norepinephrine Reuptake Inhibitor [EPC]


name: Substance P/Neurokinin-1 Receptor Antagonist [EPC]


name: alpha-Adrenergic and beta-Adrenergic Blocker [EPC]


name: Human Platelet-derived Growth Factor [EPC]


name: Aluminum Zirconium Tetrachlorohydrex GLY 20 g in 100 g TOPICAL STICK [Dove Clinical Protection Cleartone Antiperspirant and Deodorant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Suave Clinical Protection Everlasting Sunshine Antiperspirant and Deodorant]


name: Anticholinergics inhalants for obstructive airway diseases


name: Oxygen saturation sensor name:ID:Pt:Oxygen saturation device:Nom


name: Oxygen saturation sensor type:Type:Pt:Oxygen saturation device:Nom


name: Oxygen saturation sensor wrap name:ID:Pt:Oxygen saturation device:Nom


name: NCI CTEP SDC Gastrointestinal Neoplasm Category Terminology


name: SET,INFUSION ACCU-CHEK ULTRAFLEX-I 10-110


name: SET,INFUSION ACCU-CHEK ULTRAFLEX-I 8-110


name: SET,INFUSION,EXTENSION SMALL BORE BRAUN #472060


name: SPONGE,DRAIN 4IN X 4IN 16-PLY MEDLINE #NON255000Z


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND50135


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND50137


name: TRACH FILTER FOAM LARYNGEAL 2IN X 2.5IN KAPITEX #LD63019


name: TRACH STOMA PROTECTOR,FOAM 6CM X 5CM BLOM-SINGER BE6210


name: TRACH STOMA PROTECTOR,FOAM 7CM X 7CM BLOM-SINGER BE6220


name: TRACH TUBE,SZ 10 CUFFLESS/FENESTRATED SHLY #10-DCFN


name: TRACH TUBE,SZ 10 W/CUFF FENESTRATED SHLY #10-DFEN


name: TRACH TUBE,SZ 4 CUFFLESS/FENESTRATED SHLY #4-DCFN


name: TRACH TUBE,SZ 6 CUFFLESS/FENESTRATED SHLY #6-DCFN


name: TRACH TUBE,SZ 8 CUFFLESS/FENESTRATED SHLY #8-DCFN


name: TUBING,SUCTION 3/16IN X 6FT CARDINAL HEALTH #N56A


name: TRACH VALVE HOUSING,ADHESIVE BLOM-SINGER BE6070


name: TRACH VALVE HOUSING,ADHESIVE BLOM-SINGER BE6071


name: TRACH VALVE HOUSING,ADHESIVE BLOM-SINGER BE6074


name: TRACH VALVE HOUSING,ADHESIVE BLOM-SINGER BE6075


name: TRACH VALVE HOUSING,ADHESIVE BLOM-SINGER BE6076


name: NCI CTEP SDC Gastroesophageal Cancer Sub-Category Terminology


name: TRACH VALVED INSERT 20FR,BLOM-SINGER BK4100


name: BANDAGE,ELASTIC 4IN X 5YD (COBAN LF) STERILE


name: CATHETER,FOLEY SILICONE 14FR 10ML M#DYND11591


name: CATHETER,FOLEY SILICONE 16FR 10ML M#DYND11592


name: CATHETER,FOLEY SILICONE 18FR 10ML M#DYND11593


name: CATHETER,FOLEY SILICONE 20FR 10ML M#DYND11594


name: CATHETER,INTERMITTENT APOGEE 12FR H#1050


name: CATHETER,INTERMITTENT APOGEE 14FR H#1066


name: CATHETER,INTERMITTENT APOGEE 16FR H#1086


name: CATHETER,SUCTION,WHISTLE TIP 14-16FR BARD #0128150


name: DRESSING,AQUACEL FOAM 8IN X 5.5IN #420625


name: DRESSING,AQUACEL FOAM NON-ADHESIVE 4IN X 4IN #420633


name: DRESSING,AQUACEL FOAM NON-ADHESIVE 6IN X 6IN #420635


name: DRESSING,HYDROFERA BLUE TUNNELING 9MM X 6IN HBT090


name: DRESSING,LYOFOAM MAX 4IN X 4IN SC#603201


name: DRESSING,RESTORE,FOAM,SILVER 4IN X 4IN H#509345


name: DRESSING,RESTORE,FOAM,SILVER 6IN X 6IN H#509346


name: FEEDING SET,ENTERAL PUMP KENDALL #774669


name: OCTOCRYLENE 100 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OXYBENZONE 60 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Aruba Aloe Very Water Resistant Sunscreen SPF 50]


name: OCTINOXATE 7.5 g in 100 mL / OCTOCRYLENE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 2.5 g in 100 mL TOPICAL SPRAY [Kinesys Broad Spectrum SPF 30 Alcohol-Free Performance Sunscreen - Fragrance Free]


name: Titanium dioxide 60 mg in 1 mL / Zinc oxide 50 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Mineral Ultra Light Sunscreen]


name: monofluorophosphate / potassium nitrate / zinc citrate


name: cholecalciferol / polysaccharide iron complex


name: AVOBENZONE 3.0 g in 100 mL / ENSULIZOLE 1.0 g in 100 mL / OCTISALATE 5.0 g in 100 mL TOPICAL LOTION [Dove Men plus Care Hydrate Face SPF 15]


name: HOMOSALATE 80 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OXYBENZONE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [mark. For Gooness Face Antioxidant Skin Moisturizing]


name: AVOBENZONE 20 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 46 mg in 1 mL TOPICAL CREAM [INTELLIGENT BEAUTY LABS Age Defying Day Broad Spectrum SPF 20]


name: HOMOSALATE 7.296 g in 120 mL / OCTOCRYLENE 6.08 g in 120 mL / OCTISALATE 3.648 g in 120 mL / AVOBENZONE 2.1888 g in 120 mL TOPICAL LOTION [Affinia Facial Moisturizer]


name: TITANIUM DIOXIDE 121.6 mg in 1 g TOPICAL CREAM [ISA KNOX 365 BB SUNSCREEN Broad Spectrum SPF 40, PA]


name: TITANIUM DIOXIDE 121.6 mg in 1 g TOPICAL CREAM [O HUI Sun Science Ideal Cover Sunscreen Broad Spectrum]


name: Titanium Dioxide 0.302 g in 30 mL / Octinoxate 0.606 g in 30 mL TOPICAL LIQUID [ck one 3-in-1 face makeup with SPF 8 sunscreen 850 Toffee]


name: brilliant green / cod liver oil / gentian violet


name: {1 (240 ML) (benzoyl peroxide 25 MG/ML Medicated Liquid Soap) / 1 (120 ML) (salicylic acid 20 MG/ML Topical Solution) / 1 (60 ML) (sulfur 50 MG/ML Topical Solution) } Pack


name: ALUMINUM CHLOROHYDRATE 45 mg in 1 mL TOPICAL LIQUID [DawnMist Antiperspirant Deodorant]


name: Dimethicone 2 g in 100 g / Padimate O 6.6 g in 100 g / Oxybenzone 2.5 g in 100 g TOPICAL STICK [Blistex Medicated Berry Balm]


name: OCTINOXATE 6 g in 100 g / AVOBENZONE 1.7 g in 100 g TOPICAL CREAM [Renewing Antioxidant Treatment SPF 6 GNLD International]


name: AVOBENZONE 2.5 g in 100 mL / HOMOSALATE 9 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 3 g in 100 mL TOPICAL GEL [Mary Kay Foundation Primer]


name: Amyloid Beta Precursor Protein Measurement


name: NCI CTEP SDC Miscellaneous Neoplasm Category Terminology


name: NCI CTEP SDC Miscellaneous Neoplasm Sub-Category Terminology


name: NCI CTEP SDC Myeloma Sub-Category Terminology


name: NCI CTEP SDC Mesothelioma Sub-Category Terminology


name: NCI CTEP SDC Anal Cancer Sub-Category Terminology


name: CDISC Questionnaire Category Terminology


name: CDISC SDTM Reason For Treatment Terminology


name: CDISC SDTM Reason for Treatment Interruption Terminology


name: NCI CTEP SDC Rhabdoid Tumor of the Kidney Sub-Category Terminology


name: NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology


name: NCI CTEP SDC Vulvar Cancer Sub-Category Terminology


name: NCI CTEP SDC Wilms Tumor Sub-Category Terminology


name: CDISC ADAS-Cog - Word Recognition Summary Score


name: NCI CTEP SDC Non-neoplastic Disorder Category Terminology


name: CDISC SDTM Subject Characteristic Test Code Terminology


name: CDISC SDTM Findings About Test Name Terminology


name: CDISC SDTM Cardiac Valvular Stenosis Severity Terminology


name: CDISC SDTM Procedure Urgency Status Terminology


name: NCI CTEP SDC Head and Neck Squamous Cell Carcinoma Sub-Category Terminology


name: NCI CTEP SDC Myelodysplastic/Myeloproliferative Disease Sub-Category Terminology


name: CDISC SDTM Social Risk Factor Terminology


name: NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology


name: NCI CTEP SDC Chronic Lymphoid Leukemia Sub-Category Terminology


name: CDISC SDTM Treatment Episode Terminology


name: CDISC SDTM Vaccination Evidence Source Terminology


name: NCI CTEP SDC Kidney Neoplasm Category Terminology


name: NCI CTEP SDC Melanoma Sub-Category Terminology


name: {72 (calcium carbonate 1000 MG Chewable Tablet [Tums]) / 8 (calcium carbonate 750 MG Chewable Tablet [Tums]) } Pack [Tums 750 MG 8 ct - 1000 72 ct Kit]


name: Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Functional Test


name: Breast Size Different Since Cancer Treatment Question


name: Nipple Appearance Difference Since Breast Cancer Treatment question


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Domain


name: Activated Protein C Resistance Measurement


name: NCI CTEP SDC Cervical Cancer Sub-Category Terminology


name: NCI CTEP SDC Mediastinal Cancer Sub-Category Terminology


name: Immature Reticulocyte Fraction Measurement


name: NCI CTEP SDC Clear Cell Sarcoma of the Kidney Sub-Category Terminology


name: NCI CTEP SDC Vaginal Intraepithelial Neoplasia (VIN) Sub-Category Terminology


name: NCI CTEP SDC Ependymal Tumors Sub-Category Terminology


name: Acceptable (foundation metadata concept)


name: Universal restriction modifier (core metadata concept)


name: Ambiguous component (foundation metadata concept)


name: Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics


name: Adrenergics systemic drugs and other drugs for obstructive airway diseases


name: CDISC SDTM Laboratory Test Standard Character Result Terminology


name: Annotation (foundation metadata concept)


name: Annotation type reference set (foundation metadata concept)


name: Attribute type (foundation metadata concept)


name: counseling for family member of drug abuser (treatment)


name: CDISC SDTM Thrombolysis in Myocardial Infarction Flow Responses Terminology


name: Entire term case sensitive (core metadata concept)


name: Alpha glucosidase inhibitors, blood glucose lowering


name: HMG CoA reductase inhibitors, plain lipid modifying drugs


name: Parasympathomimetics, antiglaucoma preparations and miotics


name: Oxidized low density lipoprotein measurement


name: Beta-lactamase inhibitors, systemic penicillins


name: Non-selective beta-adrenoreceptor agonists for systemic use


name: NCI CTEP SDC Adrenal Cancer Sub-Category Terminology


name: External cephalic version outcome:Find:Pt:^Patient:Ord


name: NCI CTEP SDC Chronic Myeloproliferative Disease Sub-Category Terminology


name: CDISC SDTM Coronary Artery Dominance Terminology


name: Clinical Opiate Withdrawal Scale Questionnaire


name: NCI CTEP SDC Germ Cell Neoplasm Category Terminology


name: NCI CTEP SDC Gestational Trophoblastic Disease Sub-Category Terminology


name: NCI CTEP SDC Endocrine Neoplasm Category Terminology


name: Hospital Anxiety and Depression Scale Questionnaire


name: dietary counseling and surveillance (treatment)


name: NCI CTEP SDC Nasopharyngeal Cancer Sub-Category Terminology


name: NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology


name: NCI CTEP SDC Non-Small Cell Lung Cancer Sub-Category Terminology


name: CDISC SDTM Reason Treatment Not Administered Terminology


name: NCI CTEP SDC Skin Neoplasm Category Terminology


name: Adult depression screening assessment:Imp:Pt:^Patient:Ord


name: Code on Dental Procedures and Nomenclature


name: Infant activity during postductal oxygen saturation measurement:Find:Pt:^Patient:Nom


name: Infant activity during preductal oxygen saturation measurement:Find:Pt:^Patient:Nom


name: CDISC SDTM Protocol Risk Assessment Response Codelist


name: NCI CTEP SDC AIDS-related Kaposi Sarcoma Sub-Category Terminology


name: Influenza virus A neuraminidase segment sequence identifier


name: CCHD newborn screening panel:-:Pt:^Patient:-


name: CDISC SDTM Mechanical Circulatory Support Placement Timing Terminology


name: CDISC ADAS-Cog - Orientation Summary Score


name: NCI CTEP SDC Merkel Cell Tumor Sub-Category Terminology


name: NCI CTEP SDC Salivary Gland Cancer Sub-Category Terminology


name: Beta-2 Glycoprotein 1 IgG Antibody Measurement


name: Third Party Regulatory Information Submitter


name: Description format (foundation metadata concept)


name: Description format reference set (foundation metadata concept)


name: NCI CTEP SDC Small Intestine Cancer Sub-Category Terminology


name: Alpha- and beta-adrenoreceptor agonist inhalants


name: Alpha- and beta-adrenoreceptor agonist, systemic drugs


name: Alpha-adrenoreceptor antagonists, peripherally acting


name: Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy


name: NCI CTEP SDC Penile Cancer Sub-Category Terminology


name: Duplicate component (foundation metadata concept)


name: adjustment and management of infusion pump (treatment)


name: CDISC SDTM Cardiac Valvular Regurgitation Severity Terminology


name: NCI CTEP SDC Vaginal Cancer Sub-Category Terminology


name: opium alkaloids and derivative combination cough suppressants


name: Other intestinal adsorbent combinations in ATC


name: Platelet aggregation inhibitor combinations excl. heparin


name: local opthalmologic anesthetic combinations


name: insulins and analogs for injection combinations, long-acting


name: Insulins and analogs for injection, intermediate-acting combined with fast-acting- combinations


name: combination drugs used in erectile dysfunction


name: otologic analgesic and anesthetic combinations


name: Combination solutions for parenteral nutrition


name: Other antifungal combinations for topical use in ATC


name: Insulins and analogs for injection, intermediate-acting combinations


name: expectorant combinations excluding combinations with cough suppressants


name: Antiinfective irrigating solution combinations


name: Peroxide anti-acne preparations for topical use


name: Name of facility infant transferred to:ID:Pt:Facility:Nom


name: Name of facility mother transferred from


name: Name of facility mother transferred from:ID:Pt:Facility:Nom


name: Phosphodiesterase inhibitors, cardiac stimulant


name: Newborn age in hours:Time:Pt:^Patient:Qn


name: various antiinfectives and antiseptics for local oral treatment


name: SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE


name: Proton pump inhibitors for peptic ulcer and GORD


name: Adrenergic and dopaminergic agents combinations


name: Other irrigating solution combinations in ATC


name: various other anti-acne preparation combinations for topical use in ATC


name: other cough suppressant combinations in ATC


name: iodine I-131 therapeutic radiopharmaceuticals


name: Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


name: Oxygen saturation sensor wrap size:Type:Pt:Oxygen saturation device:Nom


name: NCI CTEP SDC AIDS-related Lymphoma Sub-Category Terminology


name: Abnormal Involuntary Movement Scale Clinical Classification


name: Oxygen saturation sensor wrap type:Type:Pt:Oxygen saturation device:Nom


name: Reason CCHD oxygen saturation screening not performed:Find:Pt:^Patient:Nom


name: Send all items of the specified type within the time window relevant to the service


name: NCI CTEP SDC Head and Neck Neoplasm Category Terminology


name: NCI CTEP SDC Head and Neck Precancerous Condition Sub-Category Terminology


name: NCI CTEP SDC Neuroblastoma Sub-Category Terminology


name: NCI CTEP SDC Neurofibromatosis Sub-Category Terminology


name: CDISC SDTM Microbial Identification Certainty Terminology


name: NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology


name: NCI CTEP SDC Retinoblastoma Sub-Category Terminology


name: NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology


name: adjustment and management of implanted hearing device (treatment)


name: Ophiopogon japonicus (Pharmacologic Substance)


name: Include all data of the selected type that represents observations made one year or less before the starting date of service


name: NCI CTEP SDC Mastocytosis Sub-Category Terminology


name: NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology


name: NCI CTEP SDC Breast Neoplasm Category Terminology


name: SNOMED CT model component module (core metadata concept)


name: Anatomical Therapeutic Chemical Classification System


name: Antiallergic nasal preparations for topical use, excl. corticosteroids


name: Antiallergic intestinal antiinflammatory drugs, excl. corticosteroids


name: Antiallergic inhalants for obstructive airway diseases, excl. corticosteroids


name: Anticholinergic mydriatics and cycloplegics


name: ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC


name: other nasal preparation combinations in ATC


name: Insulins and analogs for injection, fast-acting combinations


name: expectorant combinations, excl. combinations with cough suppressants


name: Corticosteroids and antiinfectives in combination, opthalmologic and otologic


name: English [International Organization for Standardization 639-1 code en] language reference set


name: Number of fetal deaths delivered:Num:Pt:^Patient:Qn


name: Number of infants in this delivery delivered alive:Num:Pt:^Patient:Qn


name: Protease inhibitors, direct acting antivirals


name: various other agents for local oral treatment in ATC


name: various other intestinal adsorbents in ATC


name: Existential restriction modifier (core metadata concept)


name: Arsenic compounds, for leishmaniasis and trypanosomiasis


name: OTHER ANALGESICS AND ANTIPYRETICS in ATC


name: Selective beta-2-adrenoreceptor agonists, systemic


name: Silver compounds, antiseptics and disinfectants


name: Local anesthetics for treatment of hemorrhoids and anal fissures for topical use


name: IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION


name: Iodine products, antiseptics and disinfectants


name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS


name: NCI CTEP SDC Choroid Plexus Tumors Sub-Category Terminology


name: CDISC SDTM Treatment Failure Reason Terminology


name: NCI CTEP SDC Chondrosarcoma Sub-Category Terminology


name: Neonatal Skin Risk Assessment Scale (NSRAS)


name: NCI CTEP SDC Cervical Intraepithelial Neoplasia (CIN) Sub-Category Terminology


name: Include all data of the selected type on or after the date of service


name: Include all data of the selected type on or before the date of service


name: Include all data of the selected type within or aligned to an encounter by the same service or encounter


name: NCI CTEP SDC Bone Neoplasm Category Terminology


name: Include all data of the selected type within the date window associated with the service


name: Influenza virus A hemagglutinin segment sequence identifier


name: Hamilton Anxiety Rating Scale Clinical Classification


name: CDISC Clinical Classification HAMA Test Name Terminology


name: NCI CTEP SDC Prostate Cancer Sub-Category Terminology


name: Eastern Cooperative Oncology Group Performance Status Clinical Classification


name: NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology


name: preparatory care for dialysis (treatment)


name: NCI CTEP SDC Soft Tissue Neoplasm Category Terminology


name: Soluble Transferrin Receptor Measurement


name: NCI CTEP SDC Thyroid Cancer Sub-Category Terminology


name: Platycodon grandiflorus (Pharmacologic Substance)


name: NCI CTEP SDC Astrocytoma, Low Grade Sub-Category Terminology


name: Barnes Akathisia Rating Scale Clinical Classification


name: CDISC SDTM Discharge Disposition Terminology


name: NCI CTEP SDC Meningeal Tumors Sub-Category Terminology


name: Arsenic compounds, for amoebiasis and other protozoal diseases


name: barbiturates for general anesthesia, in combination with other drugs


name: Barbiturates, hypnotics and sedatives, plain


name: BENZALKONIUM CHLORIDE 0.0012 mg in 1 mg TOPICAL SWAB [BANDAGE]


name: Erroneous component (foundation metadata concept)


name: Quaternary ammonium compounds, antiseptics and disinfectants


name: NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology


name: Visoelastic substances, ophthalmological surgical aids


name: Uniform resource locator (foundation metadata concept)


name: Universally Unique Identifier (foundation metadata concept)


name: Mineralocorticoids for systemic use, plain


name: Selective beta-2-adrenoreceptor agonist inhalants


name: Adolescent depression screening assessment


name: Adolescent depression screening assessment:Imp:Pt:^Patient:Ord


name: NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology


name: NCI CTEP SDC Eye Neoplasm Category Terminology


name: NCI CTEP SDC Osteosarcoma Sub-Category Terminology


name: NCI CTEP SDC Ovarian Germ Cell Cancer Sub-Category Terminology


name: NCI CTEP SDC Parathyroid Cancer Sub-Category Terminology


name: NCI CTEP SDC Testicular Germ Cell Cancer Sub-Category Terminology


name: CDISC SDTM Findings About Test Code Terminology


name: fitting and adjustment of partial artificial arm (treatment)


name: Beta blocking agents, antiglaucoma preparations and miotics


name: ELECTROLYTES WITH CARBOHYDRATES, ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS


name: CDISC SDTM Subject Characteristic Test Name Terminology


name: Xanthine derivatives, low-ceiling diuretics


name: Carbonic anhydrase inhibitors, antiglaucoma drugs and miotics


name: Serotonin receptor antagonists for functional gastrointestinal disorders


name: Neuraminidase inhibitors, direct acting antivirals


name: Melatonin receptor agonists, hypnotics and sedatives


name: Concept model range (foundation metadata concept)


name: NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology


name: Chemical Substance Excluding Protein or Nucleic Acid


name: NCI CTEP SDC Colorectal Cancer Sub-Category Terminology


name: NCI CTEP SDC Squamous Cell Carcinoma of the Skin Sub-Category Terminology


name: NCI CTEP SDC Uterine Cancer Sub-Category Terminology


name: fitting and adjustment of complete artificial leg


name: CDISC SDTM Drug Resistance Status Terminology


name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


name: Inappropriate component (foundation metadata concept)


name: fitting and adjustment of artificial eye (treatment)


name: adjustment and management of implanted device


name: Open reduction of fracture with internal fixation, radius and ulna


name: CCHD newborn screening interpretation:Imp:Pt:^Patient:Nom


name: fitting and adjustment of partial artificial leg


name: Limited component (foundation metadata concept)


name: Component moved elsewhere (foundation metadata concept)


name: Non-selective beta-adrenoreceptor agonist inhalants


name: Leukotriene receptor antagonists for obstructive airway diseases


name: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC


name: fitting and adjustment of complete artificial arm (treatment)


name: fitting and adjustment of dental prosthetic device


name: fitting and adjustment of external breast prosthesis (treatment)


name: fitting and adjustment of external prosthetic device (treatment)


name: adjustment and management of vascular access device


name: Plain text (foundation metadata concept)


name: counseling for family member of alcoholic (treatment)


name: Influenza virus A matrix protein segment sequence identifier


name: Opium derivatives and expectorants, Cough Suppressants and Expectorants, Combinations


name: activation of dihydropyridine-sensitive calcium channel activity


name: activation of depolarization-activated calcium channel


name: activation of egress of virus within host cell


name: inhibition of egress of virus within host cell


name: activation of convergent extension involved in axis elongation


name: inhibition of convergent extension involved in axis elongation


name: positive regulation of egg-laying behavior


name: negative regulation of egg-laying behavior


name: inhibition of response to reactive oxygen species